Search Within

Ryan Joseph Daley

Formats
  1. Journal Article (7)
  2. Meeting Abstract (5)
  3. Review (2)
  4. Research Letter (1)
Groups
  1. Clinical Pharmacy Specialists (15)
  2. Department of Medicine (10)
  3. Hematologic Malignancies, Division of (10)
  4. Adult Leukemia (9)
  5. Center for Hematologic Malignancies (9)
  6. Weinberg Fellows (4)

More Groups

People
  1. Larry Buie (7)
  2. Troy Horvat (7)
  3. Amber King (6)
  4. Jae Park (6)
  5. Martin Tallman (5)
  6. Charlene Kabel (4)

More People

Years
  1. 2022 (1)
  2. 2021 (2)
  3. 2020 (1)
  4. 2019 (2)
  5. 2018 (3)
  6. 2017 (3)

More Years

Publications
  1. Blood (5)
  2. Annals of Pharmacotherapy (3)
  3. Blood Advances (1)
  4. Cancer (1)
  5. Clinical Nephrology (1)
  6. Journal of Oncology Pharmacy Practice (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. Sage Publications (3)
  3. Dustri-Verlag Dr. Karl Feistle (1)
  4. Elsevier Ltd (1)
  5. Nature Publishing Group (1)
  6. Sage Publications Ltd. (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies
    Meeting Abstract

    Goldberg, A. D.; Horvat, T. Z.; Hsu, M.; Devlin, S. M.; Cuello, B. M.; Daley, R. J.; King, A. C.; Buie, L. W.; Glass, J. L.; Mauro, M. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Risk of hyponatremia and associated clinical characteristics in patients with acute lymphoblastic leukemia after CD19 targeted chimeric antigen receptor (CAR) T-cells
    Meeting Abstract

    Dixon, B. N.; Daley, R. J.; Horvat, T. Z.; Buie, L. W.; Hsu, M.; Latcha, S.; Brentjens, R. J.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance
    Journal Article

    Horvat, T. Z.; Pecoraro, J. J.; Daley, R. J.; Buie, L. W.; King, A. C.; Rampal, R. K.; Tallman, M. S.; Park, J. H.; Douer, D.
    Leukemia Research (2016)

    Fulltext@MSK | Save
  • Erwinia asparaginase safety and feasibility during therapy for acute lymphoblastic leukemia in adult patients with pegaspargase hypersensitivity or severe toxicity
    Meeting Abstract

    Horvat, T. Z.; Pecoraro, J. J.; Daley, R. J.; Buie, L. W.; Douer, D.
    Blood (2015)

    Fulltext@MSK | Save
  • Blinatumomab: A first-in-class bispecific T-cell engager for precursor B-cell acute lymphoblastic leukemia
    Journal Article

    Buie, L. W.; Pecoraro, J. J.; Horvat, T. Z.; Daley, R. J.
    Annals of Pharmacotherapy (2015)

    Fulltext@MSK | Save